- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 15, 2025 | 4.56M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 2.7M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 641.31K sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $0 |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $3.14M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $5.76M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $6.31M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $6.48M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $7.06M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $24.48M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $25.97M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $29.19M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $30.56M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.44 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$2.00 |
| Capex | Q1 2025 · Mar 31, 2024 | $62.94K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$3.19M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $24.82M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $21.21M |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$2.00 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $3.7M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $222.03K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.28M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.35M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $2.35M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $5.19M |
| Revenue | Q1 2025 · Mar 31, 2024 | $7.54M |